RBC Capital Keeps Their Hold Rating on Incyte (INCY)
RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) on January 21 and set a price target of $70.00.
RBC Capital Remains a Hold on Akamai (AKAM)
RBC Capital analyst Rishi Jaluria maintained a Hold rating on Akamai (AKAM – Research Report) on January 20 and set a price target of $100.00.